We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Case Study · July 28, 2021

Long-Term Response to IO Therapy After Discontinuation for Immune-Related Pneumonia in Metastatic RCC

Anti-Cancer Drugs


Additional Info

Anti-Cancer Drugs
Long-Term Response to Immuno-Oncology After Discontinuation for Immuno-Related Pneumonia in Metastatic Renal Carcinoma: A Case Report
Anticancer Drugs 2021 Jul 04;[EPub Ahead of Print], S Marco, F Simone, G Tonini, B Vincenzi, S Daniele

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading